RxDoctor Payments Data

Kyle Yang

Physical Medicine & Rehabilitation · Los Angeles, CANPI 1730521501

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (50.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $18,630 and has fallen 80.6% since, to $3,614 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,567in general payments, 2019–2025

Across 242 payments — averaging $159.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$26K
  • Boston Scientific$6K
  • Abbott$1K
  • Nalu Medical, Inc.$704
  • Stryker$597
  • AbbVie$551
  • plus $3K from 17 others

What the payments were for

  • Grants$19,35950%
  • Food & beverage$19,16750%
  • Education$420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,567 in reported general payments places this provider in the 95th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California

Medicare billing

Part B allowed, 2024
$167,704
Medicare patients
417
Services billed
1,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib36$1,535
Naproxen115$696
Cyclobenzaprine Hcl39$440
Gabapentin74$414
Diclofenac Sodium13$297
Methylprednisolone29$253
Meloxicam21$130

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →